Effectiveness of the AML-XH-99-M3 protocol for treatment of acute promyelocytic leukemia in children

Chinese Journal of Contemporary Pediatrics

Volumn 10, Issue 3, 2008, Pages 329-332

  Chen, Jing ^a   Gu, Long Jun ^a   Tang, Jing Yan ^a   Xue, Hui Liang ^a   Pan, Ci ^a   Ye, Qi Dong ^a   Jiang, Hua ^a   Dong, Lu ^a   Zhou, Min ^a   Wang, Yao Ping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acute promyelocytic leukemia; Child; Effectiveness; Treatment protocol

Indexed keywords

CYTARABINE; DAUNORUBICIN; ETOPOSIDE; RETINOIC ACID;

ADOLESCENT; AML-XH-99-M3 PROTOCOL; ARTICLE; CANCER REGRESSION; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG MEGADOSE; FEMALE; HUMAN; LEUKEMIA RELAPSE; MAINTENANCE THERAPY; MALE; OVERALL SURVIVAL; PROMYELOCYTIC LEUKEMIA; SURVIVAL RATE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; FEMALE; HUMANS; INFANT; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; TRETINOIN;

EID: 49749142006     PISSN: 10088830     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. de Botton S, Coiteux V, Chevret S, Ravon C, Vilmer E, Sanz M, et al. Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy[J]. J Clin Oncol, 2004, 22 (8):1404-1412.
2. Chinese source.
3. Frankfurt O, Tallman MS. Strategies for the treatment of acute promyelocytic leukemia[J]. J Natl Compr Canc Netw, 2006, 4 (1):37-50.
4. Testi AM, Biondi A, Lo Coco F, Moleti ML, Giona F, Vignetti M, et al. GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children [J]. Blood, 2005, 106(2):447-453.
5. Bapna A, Nair R, Tapan KS, Nair CN, Kadam P, Gladstone B, et al. All-trans-retinoic acid (ATRA): pediatric acute promyelocytic leukemia[J]. Pediatr Hematol Oncol, 1998, 15(3): 243-248.
6. Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimband E, et al. A randomized comparison of all-trans-retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia[J]. Blood, 1999, 94(4):1192-1200.
7. 3: an experience of 120 patients at a single institution[J]. Int J Hematol, 1999, 70(4): 248-260.
8. + adult acute promyelocytic leukemia and the CD34CD2 hypergranular (M3) and micrograunlar(M3v) phenotypes[J]. Haematologica, 2006, 91(3):311-316.
9. De Botton S, Dombret H, Sanz M, Mignel JS, Caillot D, Zittoun R, et al. Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia[J]. Blood, 1998, 92(8):2712-2718.
10. Ades L, Chevret S, Raffoux E, de Botton S, Guerci A, Pigneux A, et al. Is cytarabine useful in the treatment of acute promyelocytic leukemia? Results of a randomized trial from the European Acute Promyelocytic Leukemia Group[J]. J Clin Oncol, 2006, 24(36):5703-5710.